Related references
Note: Only part of the references are listed.Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases
Amit K. Maiti et al.
RHEUMATOLOGY (2010)
A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC
Kent S. Boles et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
CD226 Gly307Ser association with multiple autoimmune diseases
J. P. Hafler et al.
GENES AND IMMUNITY (2009)
Autoimmunity risk alleles in costimulation pathways
Lisa M. Maier et al.
IMMUNOLOGICAL REVIEWS (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Recombinant Soluble Human FcγR1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis
Jeff L. Ellsworth et al.
JOURNAL OF IMMUNOLOGY (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1
S. Seth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
Mattias Carlsten et al.
CANCER RESEARCH (2007)
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation
Richard V. Parry et al.
TRENDS IN IMMUNOLOGY (2007)
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
KS Peggs et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
S Tahara-Hanaoka et al.
BLOOD (2006)
Differential effects of B and T lymphocyte attenutator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts
R Tao et al.
JOURNAL OF IMMUNOLOGY (2005)
CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions
V Dardalhon et al.
JOURNAL OF IMMUNOLOGY (2005)
Gene finding for the helical cytokines
D Conklin et al.
BIOINFORMATICS (2005)
Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands
S Tahara-Hanaoka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The B7/CD28 costimulatory family in autoimmunity
ME Keir et al.
IMMUNOLOGICAL REVIEWS (2005)
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
D Pende et al.
BLOOD (2005)
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis
D Pende et al.
MOLECULAR IMMUNOLOGY (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)
S Tahara-Hanaoka et al.
INTERNATIONAL IMMUNOLOGY (2004)
Cutting edge: CD96 (Tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155)
A Fuchs et al.
JOURNAL OF IMMUNOLOGY (2004)
Involvement of heterophilic trans-interaction of Necl-5/Tage4/PVR/CD155 with nectin-3 in formation of nectin- and cadherin-based adherens junctions
T Sato et al.
GENES TO CELLS (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Poliovirus receptor CD155-targeted oncolysis of glioma
MK Merrill et al.
NEURO-ONCOLOGY (2004)
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
KE Sloan et al.
BMC CANCER (2004)
DNAM-1 and PVR regulate monocyte migration through endothelial junctions
N Reymond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155
I Ravens et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
T Okazaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Overexpression of the CD155 gene in human colorectal carcinoma
D Masson et al.
GUT (2001)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
Share Paper
